Cite

HARVARD Citation

    Moore, A. et al. (2020). Next‐generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage—Multicenter experience. Head & neck. 42 (4), pp. 599-607. [Online]. 
  
Back to record